Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Interferon-alpha therapy in Sicilian and Sardinian polytransfused thalassaemic patients with chronic hepatitis C.

Pizzarelli G, Di Gregorio F, Romeo MA, Carboni F, Gallisai D, Solinas A, Malaguarnera M, Musumeci S.

BioDrugs. 1999 Jul;12(1):55-63.

PMID:
18031162
2.

Interferon-alpha alone versus interferon-alpha plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-alpha treatment.

Tripi S, Di Gaetano G, Soresi M, Cartabellotta F, Vassallo R, Carroccio A, Anastasi G, Montalto G.

BioDrugs. 2000 Apr;13(4):299-304.

PMID:
18034536
3.

Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.

Berg T, Hoffmann RM, Teuber G, Leifeld L, Lafrenz M, Baumgarten R, Spengler U, Zeuzem S, Pape GR, Hopf U.

Liver. 2000 Dec;20(6):427-36.

PMID:
11169056
4.

Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C.

Malaguarnera M, Guccione N, Musumeci S, Brogna A, Motta M, Di Fazio I.

BioDrugs. 2004;18(1):63-70.

PMID:
14733608
5.

Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis C.

Diago M, Suárez D, García-Villarreal L, Castro A, Domínguez A, Pardo M, del Olmo JA, Pérez-Hernández F, Aguilar J, Quiroga JA, Carreño V.

J Med Virol. 2001 Aug;64(4):460-5.

PMID:
11468730
6.

Efficacy of interferon-based therapy in the treatment of thalassaemic patients with chronic hepatitis C: a meta-analysis.

Pistone G, Bertolini MC, Malaguarnera M, Musumeci S.

BioDrugs. 2000 Aug;14(2):137-40.

PMID:
18034565
7.

Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.

Piccinino F, Felaco FM, Sagnelli E, Aprea L, Messina V, Pasquale G, Filippini P, Scolastico C.

Res Virol. 1998 Sep-Oct;149(5):283-91.

PMID:
9879606
8.
9.

Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.

Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D.

Transplantation. 1995 May 27;59(10):1426-31.

PMID:
7770930
10.
11.

Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha.

Bresci G, Parisi G, Banti S, Capzia A.

J Viral Hepat. 1995;2(3):155-8.

PMID:
7493311
12.
13.

Chronic hepatitis C virus infection in renal transplant: treatment and outcome.

Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.

Clin Transplant. 2006 Nov-Dec;20(6):677-83.

PMID:
17100715
14.

Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial.

Gaeta GB, Di Virgilio D, Russo G, Stornaiuolo G, Nicolella U, Colella F, Grimaldi M, Pasquale G, Giusti G.

J Viral Hepat. 1997 May;4(3):209-14.

PMID:
9181530
15.

Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study Group.

Ferenci P, Stauber R, Steindl-Munda P, Gschwantler M, Fickert P, Datz C, Müller C, Hackl F, Rainer W, Watkins-Riedel T, Lin W, Krejs GJ, Gangl A; Austrian Hepatitis Study Group..

Eur J Gastroenterol Hepatol. 2001 Jun;13(6):699-705.

PMID:
11434597
16.

Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.

Angelico M, Gandin C, Pescarmona E, Rapicetta M, Del Vecchio C, Bini A, Spada E, Baroni CD, Capocaccia L.

Am J Gastroenterol. 1995 Feb;90(2):263-9.

PMID:
7847298
17.

Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.

Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.

Hepatogastroenterology. 1998 Nov-Dec;45(24):2282-94.

PMID:
9951911
18.

Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.

Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.

Med Sci Monit. 2000 Sep-Oct;6(5):964-70.

PMID:
11208439
19.

Differences between interferon-alpha and -beta treatment for patients with chronic hepatitis C virus infection.

Furusyo N, Hayashi J, Ohmiya M, Sawayama Y, Kawakami Y, Ariyama I, Kinukawa N, Kashiwagi S.

Dig Dis Sci. 1999 Mar;44(3):608-17.

PMID:
10080158
20.

Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.

Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Suzuki F, Akuta N, Someya T, Kumada H.

J Gastroenterol. 2003;38(2):158-63.

PMID:
12640530

Supplemental Content

Support Center